Home
About
Contact
NOTE: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Your search for
Pediatrics | All Regions
returned
60
studies.
Active, currently enrolling
Who can join
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to Less than 18 Years of Age with Alopecia Areata
Keywords:
Dermatology; Alopecia Areata; Hypotrichosis; Pathological…
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Keywords:
Lung Neoplasms; Carcinoma; Non-Small-Cell Lung; Respiratory Tract Neoplasms;…
Study Type:
INTERVENTIONAL |
Region:
Colorado
Active, currently enrolling
Who can join
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
Keywords:
Glioma; Neurofibromatoses; Neurofibromatosis 1; Neurofibroma; Neoplasms;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
Keywords:
Oncology (Pediatrics); Oncology…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, currently enrolling
Who can join
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Keywords:
Oncology (Pediatrics);Oncology (Adult);Neoplasms
Study Type:
OBSERVATIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Keywords:
Medulloblastoma; Glioma; Neoplasms; Neuroepithelial; Neuroectodermal Tumors;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Keywords:
Neuroblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations
Keywords:
Lymphoma; Neoplasms; Sarcoma; Lymphoma; Non-Hodgkin; Glioma; Neuroblastoma;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of AG-120 (Ivosidenib) in Patients With Tumors Harboring IDH1 Mutations
Keywords:
Lymphoma; Neoplasms; Sarcoma; Lymphoma; Non-Hodgkin; Glioma; Neuroblastoma;…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Enrollment complete
Who can join
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations
Keywords:
Lymphoma, Carcinoma, Neoplasms, Melanoma, Sarcoma, Lymphoma, Non-Hodgkin,…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
1
2
3
4
5
6